Epitalon

Epitalon (also spelled Epithalon or Epithalone) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the naturally occurring polypeptide Epithalamin, extracted from the pineal gland. It was developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, who studied it for over 30 years in both animal and human trials. Browse the full peptide library for related anti-aging compounds.

The primary mechanism is telomerase activation. Telomeres are the protective caps on chromosomes that shorten with each cell division. Think of them like the plastic tips on shoelaces. When they get too short, cells stop dividing properly and enter senescence. Telomerase is the enzyme that rebuilds these caps. By activating telomerase, Epitalon may slow or partially reverse cellular aging at the chromosomal level.

Epitalon is the most studied peptide specifically for longevity and anti-aging effects. For cellular energy optimization, consider combining with MOTS-c or NAD+. For mitochondrial support, SS-31 works through complementary pathways. People running longevity protocols often pair epitalon with thymosin alpha-1 for the combined telomere and immune angle. The longevity stacking approach combines multiple mechanisms for comprehensive anti-aging.

What does the research actually show? The telomerase result is real but sits in cell culture: Epitalon induced telomerase activity and telomere elongation in human fetal fibroblasts (PMID 12937682). The lifespan work is in animals, and it is narrower than the summaries suggest. In female SHR mice given roughly 30 to 40 mcg per kg subcutaneously on 5 days a month for life, mean life span did not change; the life span of the last 10 percent of survivors rose 13.3 percent and maximum life span rose 12.3 percent (mouse study, not a human dose, PMID 14501183). The often repeated 11 to 16 percent average life extension figure is not what that study reported. Human work comes almost entirely from Khavinson's group in St Petersburg and used epithalamin, a pineal extract, rather than the tetrapeptide sold as Epitalon. Treat this as early-stage research, not a proven life extension drug.

On dosing: community practice describes a short pulsed course, commonly reported at 5 to 10mg subcutaneously for 10 to 20 days, repeated once or twice a year (community practice, no trial). No clinical trial has established a human dose or a course length for Epitalon, and no approved label exists in any market to cite instead, so those numbers come from the community rather than from evidence. The rationale for pulsing rather than running it continuously is that nobody has tested continuous use at all. Dose and schedule are a prescriber decision. Epitalon is sometimes discussed alongside nootropic peptides like Semax or the anxiolytic Selank for brain-aging support.

In Vietnam, Epitalon is available research-grade from regional suppliers but not at pharmacies or hospitals. It is popular in the longevity biohacker community in HCMC and Hanoi. For verified suppliers, see the supply index. Verify purity via the COA guide. For legal context, see the peptide legality guide. For combining Epitalon with NAD+ IV therapy in Vietnam, see the NAD+ longevity guide.